Abstract
The global sheep industry is changing dramatically to serve its diverse customers and in response to liberalised international trade agreements and resculptured (reduced) national subsidies. A drive for efficiency gains together with greater awareness of animal related public health issues means that there is a focus on disease reduction and welfare issues in sheep husbandry. Particular advances have been made in the rational use of anthelmintics, antibiotics and anti-inflammatory analgesics in sheep and veterinarians and drug licensing authorities must utilise these advances to the benefit of the health of the sheep industry.
Original language | English |
---|---|
Pages (from-to) | 7-12 |
Journal | Small Ruminant Research |
Volume | 62 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - 2006 |